Presentation is loading. Please wait.

Presentation is loading. Please wait.

Disjunction of the polarity of the Golgi apparatus and the nuclear dense lamina (NDL) in Spink2−/− round spermatids and presence of multivesicular bodies.

Published byFelicity Beverly Newman Modified over 5 years ago

Similar presentations

Presentation on theme: "Disjunction of the polarity of the Golgi apparatus and the nuclear dense lamina (NDL) in Spink2−/− round spermatids and presence of multivesicular bodies."— Presentation transcript:

1 Disjunction of the polarity of the Golgi apparatus and the nuclear dense lamina (NDL) in Spink2−/− round spermatids and presence of multivesicular bodies in the cytoplasm of Spink2−/− round spermatids Disjunction of the polarity of the Golgi apparatus and the nuclear dense lamina (NDL) in Spink2−/− round spermatids and presence of multivesicular bodies in the cytoplasm of Spink2−/− round spermatids Partial section of a Spink2−/− round spermatid observed by EM showing the spatial disjunction of the Golgi apparatus and the NDL. NDL is evidenced by apposition of dense material on the nuclear side of the inner nuclear membrane. Another hallmark of this specialized area of the nuclear envelope is the tight apposition of both inner and outer nuclear membranes along the NDL. M, mitochondria. Scale bar, 2 μm.Partial section of a Spink2−/− round spermatid observed by EM showing structures corresponding to multivesicular bodies (MVB). M, mitochondria; NE, nuclear envelope; NDL, nuclear dense lamina. Scale bar, 2 μm. Zine‐Eddine Kherraf et al. EMBO Mol Med. 2017;emmm © as stated in the article, figure or figure legend

Download ppt "Disjunction of the polarity of the Golgi apparatus and the nuclear dense lamina (NDL) in Spink2−/− round spermatids and presence of multivesicular bodies."

Similar presentations

Animal Cell e. cytoplasm a. vacuole m. centriole i. Cell membrane

Animal Cell e. cytoplasm a. vacuole m. centriole i. Cell membrane
Do Now Collect the Handouts Turn your lab into the bin. Do Now:

Do Now Collect the Handouts Turn your lab into the bin. Do Now:
Effects of inhibiting inflammatory cell recruitment on fracture healing Treatment with CCR2 antagonist, INCB3344, led to impaired fracture healing compared.

Effects of inhibiting inflammatory cell recruitment on fracture healing Treatment with CCR2 antagonist, INCB3344, led to impaired fracture healing compared.
Impact of triple combination of gemcitabine‐based chemoirradiation with anti‐PD‐L1 in the KPC tumor allograft Impact of triple combination of gemcitabine‐based.

Impact of triple combination of gemcitabine‐based chemoirradiation with anti‐PD‐L1 in the KPC tumor allograft Impact of triple combination of gemcitabine‐based.
The Cell.

The Cell.
Surface distribution of immunogold‐labelled PS I (A–C) and ATP synthase (D–F) complexes. Surface distribution of immunogold‐labelled PS I (A–C) and ATP.

Surface distribution of immunogold‐labelled PS I (A–C) and ATP synthase (D–F) complexes. Surface distribution of immunogold‐labelled PS I (A–C) and ATP.
Metabolic effects of TUG‐891 are reduced or absent in GPR120‐deficient mice Metabolic effects of TUG‐891 are reduced or absent in GPR120‐deficient mice.

Metabolic effects of TUG‐891 are reduced or absent in GPR120‐deficient mice Metabolic effects of TUG‐891 are reduced or absent in GPR120‐deficient mice.
Detection by TEM of integral HIV‐1 capsids at the cytoplasmic face of the nuclear pore. Detection by TEM of integral HIV‐1 capsids at the cytoplasmic face.

Detection by TEM of integral HIV‐1 capsids at the cytoplasmic face of the nuclear pore. Detection by TEM of integral HIV‐1 capsids at the cytoplasmic face.
PERK activator reduces behavioral deficits and neurodegeneration in vivo PERK activator reduces behavioral deficits and neurodegeneration in vivo A–CYoung.

PERK activator reduces behavioral deficits and neurodegeneration in vivo PERK activator reduces behavioral deficits and neurodegeneration in vivo A–CYoung.
Eukaryotic Cell Structure

Eukaryotic Cell Structure
The major protein‐translocation machineries in eukaryotic and prokaryotic cells. The major protein‐translocation machineries in eukaryotic and prokaryotic.

The major protein‐translocation machineries in eukaryotic and prokaryotic cells. The major protein‐translocation machineries in eukaryotic and prokaryotic.
Neuro‐inflammatory cytokines, brain microglial activation, and working memory deficits are normalized using LV.IDS.ApoEII, but not LV.IDS in MPS II mice.

Neuro‐inflammatory cytokines, brain microglial activation, and working memory deficits are normalized using LV.IDS.ApoEII, but not LV.IDS in MPS II mice.
Steve Harris SPASH - Biology

Steve Harris SPASH - Biology
The gene encoding TP53INP1 is expressed in pancreatic endocrine cells A, B(A, B) Immunocytofluorescent staining of TP53INP1 (red) and insulin (green) in.

The gene encoding TP53INP1 is expressed in pancreatic endocrine cells A, B(A, B) Immunocytofluorescent staining of TP53INP1 (red) and insulin (green) in.
PbA‐specific CD4 T‐cell responses are maximal at day 6 post‐pRBC infection PbA‐specific CD4 T‐cell responses are maximal at day 6 post‐pRBC infection Proportion.

PbA‐specific CD4 T‐cell responses are maximal at day 6 post‐pRBC infection PbA‐specific CD4 T‐cell responses are maximal at day 6 post‐pRBC infection Proportion.
AAV8‐hAAT‐FGF21 treatment improves liver fibrosis

AAV8‐hAAT‐FGF21 treatment improves liver fibrosis
Treatment with FGF21‐encoding vectors reverses hepatic steatosis and fibrosis Treatment with FGF21‐encoding vectors reverses hepatic steatosis and fibrosis.

Treatment with FGF21‐encoding vectors reverses hepatic steatosis and fibrosis Treatment with FGF21‐encoding vectors reverses hepatic steatosis and fibrosis.
CAR T cell dose and percentages of CAR‐positive cells within CAR T cell products CAR T cell dose and percentages of CAR‐positive cells within CAR T cell.

CAR T cell dose and percentages of CAR‐positive cells within CAR T cell products CAR T cell dose and percentages of CAR‐positive cells within CAR T cell.
TNFR1 deficiency protects against morphological alterations in the choroid plexus of APP/PS1tg/wt mice determined by TEM TNFR1 deficiency protects against.

TNFR1 deficiency protects against morphological alterations in the choroid plexus of APP/PS1tg/wt mice determined by TEM TNFR1 deficiency protects against.
TR suppresses the assembly of NLRP3 inflammasome

TR suppresses the assembly of NLRP3 inflammasome

Similar presentations

Ads by Google